AHCL vs INDORAMA: Stock Comparison
Head-to-head financial and trading comparison between Anlon Healthcare Limited (AHCL) and Indo Rama Synthetics (India) Limited (INDORAMA) in the Cross-Sector Peers sector.
AHCL
NSE: AHCLINDORAMA
NSE: INDORAMAKey Metrics Comparison Table
| Metric | AHCL | INDORAMA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹28.11 | ₹92.39 | — |
| 1-Year Price Return | -80.59% | +140.29% | INDORAMA (220.88% higher) |
| 52-Week High | ₹144.82 | ₹106.55 | — |
| 52-Week Low | ₹13.11 | ₹35.16 | — |
| 30-Day Annualized Volatility | 89.83% | 82.26% | INDORAMA (Steadier) |
| 30-Day Average Daily Volume | 39,844,430 | 2,295,337 | AHCL (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between AHCL and INDORAMA, which stock gave better returns over the last year?
INDORAMA has outperformed AHCL over the past 12 months with a gain of 140.29% compared to -80.59%.
Which stock is less volatile: AHCL or INDORAMA?
INDORAMA demonstrated lower price volatility (82.26% annualized) compared to AHCL (89.83%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of AHCL vs INDORAMA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are AHCL and INDORAMA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.